CROSIGNANI, PIERGIORGIO
 Distribuzione geografica
Continente #
EU - Europa 8.031
NA - Nord America 7.719
AS - Asia 6.876
Continente sconosciuto - Info sul continente non disponibili 1.192
SA - Sud America 581
AF - Africa 133
OC - Oceania 48
AN - Antartide 1
Totale 24.581
Nazione #
US - Stati Uniti d'America 7.409
GB - Regno Unito 3.114
SG - Singapore 2.000
CN - Cina 1.986
SE - Svezia 1.029
IT - Italia 860
RU - Federazione Russa 792
VN - Vietnam 605
DE - Germania 576
HK - Hong Kong 562
BR - Brasile 370
BD - Bangladesh 359
FR - Francia 350
TR - Turchia 327
KR - Corea 309
IN - India 304
UA - Ucraina 302
NL - Olanda 253
IE - Irlanda 233
CA - Canada 203
FI - Finlandia 185
EU - Europa 169
ID - Indonesia 86
CO - Colombia 80
JP - Giappone 67
AR - Argentina 51
ES - Italia 51
PL - Polonia 47
MX - Messico 45
GR - Grecia 43
AU - Australia 40
PH - Filippine 36
BE - Belgio 34
EC - Ecuador 28
IQ - Iraq 28
PK - Pakistan 28
CI - Costa d'Avorio 27
ZA - Sudafrica 26
AT - Austria 25
MY - Malesia 24
TH - Thailandia 23
CL - Cile 18
IR - Iran 18
SA - Arabia Saudita 18
TW - Taiwan 17
PT - Portogallo 15
MA - Marocco 14
CZ - Repubblica Ceca 13
EG - Egitto 13
NG - Nigeria 12
NO - Norvegia 12
RO - Romania 12
HU - Ungheria 11
JM - Giamaica 11
UZ - Uzbekistan 11
AE - Emirati Arabi Uniti 10
CH - Svizzera 10
HN - Honduras 10
PE - Perù 10
KE - Kenya 9
TT - Trinidad e Tobago 9
DK - Danimarca 8
LT - Lituania 8
NZ - Nuova Zelanda 8
UY - Uruguay 8
AZ - Azerbaigian 7
BG - Bulgaria 7
CR - Costa Rica 7
JO - Giordania 7
RS - Serbia 7
TN - Tunisia 7
BO - Bolivia 6
EE - Estonia 6
ET - Etiopia 6
GT - Guatemala 5
KZ - Kazakistan 5
LB - Libano 5
NP - Nepal 5
VE - Venezuela 5
DO - Repubblica Dominicana 4
IS - Islanda 4
LU - Lussemburgo 4
LV - Lettonia 4
PY - Paraguay 4
SV - El Salvador 4
BY - Bielorussia 3
DZ - Algeria 3
IL - Israele 3
KW - Kuwait 3
MD - Moldavia 3
MM - Myanmar 3
OM - Oman 3
PR - Porto Rico 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AF - Afghanistan, Repubblica islamica di 2
AL - Albania 2
AM - Armenia 2
BB - Barbados 2
BF - Burkina Faso 2
BH - Bahrain 2
Totale 23.518
Città #
Southend 2.858
Singapore 1.259
Ashburn 564
Chandler 533
Hong Kong 521
Seattle 466
San Jose 418
Beijing 383
Council Bluffs 353
Santa Clara 345
Princeton 323
Wilmington 290
Milan 230
Dublin 228
Redmond 212
Dallas 208
Jacksonville 197
Los Angeles 194
Houston 180
Ann Arbor 161
Mountain View 159
Boardman 150
Nanjing 148
Ho Chi Minh City 145
Sakarya 135
Lauterbourg 134
Woodbridge 133
Fairfield 125
Bengaluru 122
Hanoi 122
Buffalo 117
Des Moines 111
Moscow 102
Dearborn 99
New York 89
The Dalles 82
Guangzhou 80
Jinan 75
Shanghai 72
Berlin 70
Serra 69
Toronto 68
Columbus 64
Dong Ket 64
Bogotá 62
Shenyang 61
Redwood City 60
Andover 58
Tianjin 54
Nanchang 53
Tokyo 50
Phoenix 47
Cangzhou 46
Falls Church 46
Somerville 46
Changsha 44
São Paulo 44
Hefei 42
Cambridge 41
Pisa 38
Shenzhen 37
Frankfurt am Main 35
Chicago 34
Eitensheim 34
Hebei 34
Ottawa 34
Warsaw 33
Helsinki 32
Rome 32
Washington 32
Bitonto 30
Jakarta 30
San Diego 30
Bangalore 28
Abidjan 25
Da Nang 25
Seoul 25
Zhengzhou 25
Athens 24
Brussels 24
Hangzhou 24
Mumbai 23
Ningbo 23
Fuzhou 19
Montreal 19
Haiphong 18
Kunming 18
Munich 18
Atlanta 17
Auburn Hills 17
Pune 17
Jiaxing 16
London 16
Brooklyn 15
Kent 15
Naples 15
Redondo Beach 15
Sunnyvale 15
Taizhou 15
Chengdu 14
Totale 14.202
Nome #
Progestogens for endometriosis : forward to the past 1.001
Bone fractures after menopause 666
Simultaneous prevention of unintended pregnancy and STIs: A challenging compromise 432
Endometriosis: current and future medical therapies 327
Hormones and cardiovascular health in women 289
Breast cancer risk with postmenopausa hormonal treatment 261
Surgery for endometriosis-associated infertility : a pragmatic approach 257
Mutations in the coding region of the FOXL2 gene are not a major cause of idiopathic premature ovarian failure 254
Endometriosis: current therapies and new pharmacological developments 251
Metabolic syndrome and postmenopausal breast cancer in the ORDET cohort : a nested case-control study 244
The use and effectiveness of in vitro fertilization in women with endometriosis : the surgeon's perspective 241
Postoperative oral contraceptive exposure and risk of endometrioma recurrence 239
Effect of the ethinylestradiol/norelgestromin contraceptive patch on body composition. Results of bioelectrical impedance analysis in a population of Italian women 237
Fertility and ageing 234
Association between endometriosis stage, lesion type, patient characteristics and severity of pelvic pain symptoms : a multivariate analysis of over 1000 patients 225
The effect of surgery for symptomatic endometriosis: the other side of the story 214
Gonadotropin-releasing hormone agonist treatment before abdominal myomectomy : a controlled trial 213
Continuous use of an oral contraceptive for endometriosis-associated recurrent dysmenorrhea that does not respond to a cyclic pill regimen 212
Reproductive performance in infertile women with rectovaginal endometriosis: Is surgery worthwhile? 212
Endometrial bleeding 210
Gestrinone versus a gonadotropin-releasing hormone agonist for the treatment of pelvic pain associated with endometriosis: A multicenter, randomized, double-blind study 210
Treatment of symptomatic rectovaginal endometriosis with an estrogen-progestogen combination versus low-dose norethindrone acetate 209
Female contraception over 40 207
Fibroids and female reproduction : a critical analysis of the evidence 206
Endometriosis: preoperative and postoperative medical treatment 204
Asymmetry in distribution of diaphragmatic endometriotic lesions: evidence in favour of the menstrual reflux theory 200
Satisfaction and compliance in hormonal contraception: the result of a multicentre clinical study on women's experience with the ethinylestradiol/norelgestromin contraceptive patch in Italy 200
Menstrual characteristics in women with and without endometriosis 195
Deep endometriosis: definition, pathogenesis, and clinical management 194
Waiting for Godot : a commonsense approach to the medical treatment of endometriosis 194
Deep endometriosis conundrum: evidence in favor of a peritoneal origin 190
Hysteroscopic myomectomy: long-term effects on menstrual pattern and fertility 188
Endometriosis and pelvic pain: relation to disease stage and localization 187
Surgical management of endometriosis 187
Progestinici ed endometriosi 185
Abdominal myomectomy for infertility: a comprehensive review 185
Nutrition and reproduction in women 182
A levonorgestrel-releasing intrauterine system for the treatment of dysmenorrhea associated with endometriosis: a pilot study 182
Lateral distribution of recurrent ovarian endometriotic cysts 182
Analysis of p53 and ras gene mutations in endometriosis 182
Comparison of a levonorgestrel-releasing intrauterine device versus expectant management after conservative surgery for symptomatic endometriosis: a pilot study 180
Effectiveness of sonohysterography in infertile patient work-up : a comparison with transvaginal ultrasonography and hysteroscopy 180
Damage to ovarian reserve associated with laparoscopic excision of endometriomas : a quantitative rather than a qualitative injury 179
Advances in the management of endometriosis : an update for clinicians 179
Evidence for asymmetric distribution of lower intestinal tract endometriosis 178
Venous thromboembolism in women : a specific reproductive health risk 175
Randomized comparison of vaporizing electrode and cutting loop for endometrial ablation 173
Gynaecological endocrinology 172
Comparison of placebo and bromocriptine in the treatment of patients with normoprolactinaemic amenorrhoea 172
Non-invasive diagnosis of endometriosis: the goal or own goal? 171
Subcutaneous depot medroxyprogesterone acetate versus leuprolide acetate in the treatment of endometriosis-associated pain 168
Why after 50 years of effective contraception do we still have unintended pregnancy? A European perspective 165
IVF, from the past to the future: the inheritance of the Capri Workshop Group 164
A gonadotropin-releasing hormone agonist versus a low-dose oral contraceptive for pelvic pain associated with endometriosis 162
Noncontraceptive health benefits of combined oral contraception 162
Comparison of GnRH agonists and antagonists in assisted reproduction cycles of patients at high risk of ovarian hyperstimulaton syndrome 160
Is ureteral endometriosis an asymmetric disease? 160
Adenomyosis: a déjà vu? 160
Leuprolide in a 3-monthly versus a monthly depot formulation for the treatment of symptomatic endometriosis: a pilot study 159
The incessant menstruation hypothesis : a mechanistic ovarian cancer model with implications for prevention 157
Reply: Oral contraceptives and the endometriosis domino effect 157
Circatrigintan rectal temperature and endocrine rhythms of clinically healthy, menstrually cycling women 157
Does laparoscopic removal of nonendometriotic benign ovarian cysts affect ovarian reserve? 156
Site of origin of epithelial ovarian cancer: the endometriosis connection 156
Abnormal uterine bleeding associated with iron-deficiency anemia. Etiology and role of hysteroscopy 156
Treatment with a gonadotrophin releasing hormone agonist before endometrial resection: a multicentre, randomised controlled trial 155
Looking to Europe: something's changed in Italy 154
Evidence for asymmetric distribution of sciatic nerve endometriosis 154
Laparoscopy versus laparotomy in conservative surgical treatment for severe endometriosis 154
Hormonal contraception without estrogens 154
A modified technique for correction of the complete septate uterus 151
Laparoscopic uterosacral ligament resection for dysmenorrhea associated with endometriosis : results of a randomized, controlled trial 149
Genetic aspects of female reproduction 149
Current treatment issues in female hyperprolactinaemia 148
Progestins for symptomatic endometriosis: a critical analysis of the evidence 148
Adenomyosis at hysterectomy: a study on frequency distribution and patient characteristics 148
Minimal and mild endometriosis. Is there anything new under the sun? 148
Towards a more pragmatic and wiser approach to infertility care 147
Is cystic ovarian endometriosis an asymmetric disease? 146
Anthropometric indicators and response to gonadotrophin for ovulation induction 146
Should endometriomas be treated before IVF-ICSI cycles? 145
Reproductive performance, pain recurrence and disease relapse after conservative surgical treatment for endometriosis : the predictive value of the current classification system 145
Lateral distribution of nonendometriotic benign ovarian cysts 143
Goserelin (Zoladex) and the anaemic patient 142
Veralipride for hot flushes during gonadotropin-releasing hormone agonist treatment 142
Medical treatment for rectovaginal endometriosis : what is the evidence? 141
Video display terminal use during pregnancy and reproductive outcome--a meta-analysis 141
Current treatment issues in female hyperprolactinemia 139
Does a “peritoneal circulation” really exists? 138
Endometriosi 137
A gonadotrophin-releasing hormone agonist compared with expectant management after conservative surgery for symptomatic endometriosis 136
Hysterectomy for benign gynecologic disorders - When and why? 136
Metroplasty for the complete septate uterus: does cervical sparing matter? 136
Health and fertility in World Health Organization group 2 anovulatory women 136
Clinical overview of hormonal contraception with special emphasis on long-term effects 132
Preventing high-order multiple pregnancies during controlled ovarian hyperstimulation and intrauterine insemination: 3 years’ experience using low-dose recombinant follicle-stimulating hormone and gonadotropin-releasing hormone antagonists. 131
Transvaginal ultrasonography versus uterine needle biopsy in the diagnosis of diffuse adenomyosis 131
Veralipride for hot flushes induced by a gonadotropin-releasing hormone agonist: a controlled study 131
Cyproterone acetate versus a continuous monophasic oral contraceptive in the treatment of recurrent pelvic pain after conservative surgery for symptomatic endometriosis 130
Association of Stein-Leventhal syndrome with the incidence of postmenopausal breast carcinoma in a large prospective study of women in Iowa 130
Totale 19.239
Categoria #
all - tutte 62.266
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 62.266


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.321 0 51 43 123 100 119 118 82 101 142 163 279
2022/20231.981 267 208 156 251 232 413 26 122 165 26 62 53
2023/2024949 49 86 33 32 184 60 45 72 16 81 142 149
2024/20252.658 84 224 46 274 299 143 47 356 174 229 252 530
2025/20266.287 591 296 630 522 745 481 707 401 701 385 453 375
2026/2027698 303 395 0 0 0 0 0 0 0 0 0 0
Totale 24.581